The most notable companies in this group are AstraZeneca PLC (NASDAQ:AZN).
The investment seeks capital appreciation.
The fund is a diversified fund that invests for the long term primarily in equity securities in the form of common stock of non-U.S. growth companies. It seeks to diversify its investments among several developed countries and developing countries throughout the world, although the fund may only invest up to 35% of its net assets in developing countries. Developing countries include countries in the MSCI Emerging Markets (EM) Index, countries in the MSCI Frontier Markets (FM) Index and other countries determined by the Adviser to be developing countries based on classifications.
The average market capitalization across the Baron International Growth R6 MF is 102.6B. The market cap for tickers in the group ranges from 7.42B to 200.64B. LIN holds the highest valuation in this group at 200.64B. The lowest valued company is EDR at 7.42B.
The average weekly volume growth across all stocks in the Baron International Growth R6 MF was 82%. For the same stocks of the MF, the average monthly volume growth was -36% and the average quarterly volume growth was -38%
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Valuation Rating: 52
P/E Growth Rating: 54
Price Growth Rating: 46
SMR Rating: 53
Profit Risk Rating: 34
Seasonality Score: 25 (-100 ... +100)